95 related articles for article (PubMed ID: 24648670)
21. Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.
Kang M; Ha SY; Cho HY; Chung DH; Kim NR; An J; Lee S; Seok JY; Jeong J
J Pathol Transl Med; 2020 Jan; 54(1):112-118. PubMed ID: 31964113
[TBL] [Abstract][Full Text] [Related]
22. The Correlation of Papanicolaou Smears and Clinical Features to Identify the Common Risk Factors for Cervical Cancer: A Retrospective and Descriptive Study from a Tertiary Care Hospital in Trinidad.
Umakanthan S; Bukelo MM; Ghany S; Gay D; Gilkes T; Freeman J; Francis A; Francis K; Gajadhar G; Fraser J
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992281
[No Abstract] [Full Text] [Related]
23. Evaluation of p16INK4a in cervical lesion of premenopausal and postmenopausal women.
Bolanca IK; Ciglar S
Coll Antropol; 2007 Apr; 31 Suppl 2():107-11. PubMed ID: 17600938
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of cervical intraepithelial lesion in postmenopausal women].
Zhang X; Guan XJ; Li JQ; Zhang LH; Yang JH
Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):705-710. PubMed ID: 30369128
[No Abstract] [Full Text] [Related]
25. Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: a hospital-based study.
Ansari M; Mehdi G; Arif SH; Ansari H; Khan T
Diagn Cytopathol; 2012 Nov; 40(11):976-83. PubMed ID: 21538964
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.
Ssedyabane F; Niyonzima N; Nambi Najjuma J; Birungi A; Atwine R; Tusubira D; Randall TC; Castro CM; Lee H; Ngonzi J
SAGE Open Med; 2024; 12():20503121241252265. PubMed ID: 38764539
[TBL] [Abstract][Full Text] [Related]
27. A Study of Pap Smear in HIV-Positive Females.
Madan A; Patil S; Nakate L
J Obstet Gynaecol India; 2016 Dec; 66(6):453-459. PubMed ID: 27821987
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of cervicovaginal Pap smears in newly established tertiary care medical institute.
Sethy MR; Nigam JS; Rath A; Sharma A; Prabhala S; Pradeep I
Cytojournal; 2023; 20():20. PubMed ID: 37681076
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors associated with precancerous cervical lesions among women in two cities in Cameroon.
Wabo B; Nsagha DS; Nana TN; Assob CJN
Pan Afr Med J; 2022; 41():276. PubMed ID: 35784594
[TBL] [Abstract][Full Text] [Related]
30. Histomorphological Spectrum of Cervical Lesions in a Rural Hospital.
Vijayakumar S; Sinha P; Krishnamurthy D
Cureus; 2021 Sep; 13(9):e18293. PubMed ID: 34722069
[TBL] [Abstract][Full Text] [Related]
31. Well-armed is well started: A population-based study to assess risk stratification in potentially premalignant oral epithelial lesions.
Venugopal R; Bavle RM; Muniswamappa S; Makarla S; Hosthor SS; Shetty P
J Oral Maxillofac Pathol; 2020; 24(2):237-244. PubMed ID: 33456231
[TBL] [Abstract][Full Text] [Related]
32. An in vivo cytogenetic analysis of human oral squamous cell carcinoma.
Mohanta A; Mohanty PK; Parida G
South Asian J Cancer; 2015; 4(3):123-6. PubMed ID: 26942142
[TBL] [Abstract][Full Text] [Related]
33. Retrospective sequential trend analysis of neoplasms reported in a tertiary care hospital of district Etawah, Uttar Pradesh.
Shukla SK; Sachan D; Bajpai PK; Srivastava DK; Verma MK; Agarwal T
J Family Med Prim Care; 2021 Mar; 10(3):1419-1424. PubMed ID: 34041188
[TBL] [Abstract][Full Text] [Related]
34. Role of Geminin as a Tool for Augmenting Accurate Diagnosis of Cervical Neoplasia.
Bagde ND; Bagde MN; Agrawal S; Nayak P; Negi SS; Rajbhar S; Hussain N
Cureus; 2024 Mar; 16(3):e56864. PubMed ID: 38659554
[TBL] [Abstract][Full Text] [Related]
35. The Bethesda System for reporting cervical cytology.
Pangarkar MA
Cytojournal; 2022; 19():28. PubMed ID: 35673697
[TBL] [Abstract][Full Text] [Related]
36. A community-based cervical cancer screening program in Alappuzha district of Kerala using camp approach.
Mohan L; Karthika M
J Family Med Prim Care; 2022 Mar; 11(3):1152-1157. PubMed ID: 35495785
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls.
Yogeshkumar S; Anderson J; Lu E; Kenyi E; Mensa M; Thaler K; Antartani R; Donimath K; Patil B; Chikaraddi S; Bidri S; Biradar A; Gudadinni MR; Lokare L; Yenokyan G; Bellad MB; Goudar SS; Derman R; Revankar A; Patil H; Wani R; Kangle R; Chavan RY; Nagmoti MB; Kabadi YM; Reddy P; Vernekar S; Hipparagi S; Patil V; Dalal A
Trials; 2021 Dec; 22(1):915. PubMed ID: 34903244
[TBL] [Abstract][Full Text] [Related]
38. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.
Bao H; Sun X; Zhang Y; Pang B; Li H; Zhou L; Wu F; Cao D; Wang J; Turic B; Wang L
Cancer Med; 2020 Sep; 9(18):6896-6906. PubMed ID: 32697872
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.
Shin SS; Carpenter CL; Ekstrand ML; Wang Q; Grover S; Zetola NM; Yadav K; Sinha S; Nyamathi AM
Int J STD AIDS; 2019 May; 30(6):586-595. PubMed ID: 30813859
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]